Mafalda Ramos

Cost-effectiveness analysis of the SAPIEN 3 TAVI valve compared with surgery in intermediate-risk patients

G Goodall, Mark Lamotte, Mafalda Ramos et al. · Journal of Medical Economics · 2018 · 43 citations · Full text

Evaluating the Ability of Economic Models of Diabetes to Simulate New Cardiovascular Outcomes Trials: A Report on the Ninth Mount Hood Diabetes Challenge

Lei Si, Michael Willis, Christian Asseburg et al. · Value in Health · 2020 · 42 citations · Full text

Obesity, Metabolic Syndrome, Diabetes Management +11

Cost-Effectiveness Analysis of Empagliflozin in Comparison to Sitagliptin and Saxagliptin Based on Cardiovascular Outcome Trials in Patients with Type 2 Diabetes and Established Cardiovascular Disease

Mafalda Ramos, V. Foos, Anastasia Ustyugova et al. · Diabetes Therapy · 2019 · 36 citations · Full text

Assessing the Burden of Type 2 Diabetes in China Considering the Current Status-Quo Management and Implications of Improved Management Using a Modeling Approach

V. Foos, Ke Wang, Phil McEwan et al. · Value in Health Regional Issues · 2018 · 33 citations

Obesity, Metabolic Syndrome, Disease Management +12

Long-Term Cost-Effectiveness Analyses of Empagliflozin Versus Oral Semaglutide, in Addition to Metformin, for the Treatment of Type 2 Diabetes in the UK

Mafalda Ramos, Michael H. Cummings, Anastasia Ustyugova et al. · Diabetes Therapy · 2020 · 24 citations · Full text